Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Salomone, B; Ponti, R; Gasco, MR; Ugazio, E; Quaglino, P; Osella-Abate, S; Bernengo, MG
   In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction
   CLINICAL & EXPERIMENTAL METASTASIS
   
   B. Salomone et al., "In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction", CLIN EXP M, 18(8), 2001, pp. 663-673
2. Cavalli, R; Zara, GP; Caputo, O; Bargoni, A; Fundaro, A; Gasco, MR
   Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I - A pharmacokinetic study
   PHARMACOLOGICAL RESEARCH
   
   R. Cavalli et al., "Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I - A pharmacokinetic study", PHARMAC RES, 42(6), 2000, pp. 541-545
3. Cavalli, R; Caputo, O; Gasco, MR
   Preparation and characterization of solid lipid nanospheres containing paclitaxel
   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
   
   R. Cavalli et al., "Preparation and characterization of solid lipid nanospheres containing paclitaxel", EUR J PH SC, 10(4), 2000, pp. 305-309
4. Miglietta, A; Cavalli, R; Bocca, C; Gabriel, L; Gasco, MR
   Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel
   INTERNATIONAL JOURNAL OF PHARMACEUTICS
   
   A. Miglietta et al., "Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel", INT J PHARM, 210(1-2), 2000, pp. 61-67
5. Marengo, E; Cavalli, R; Caputo, O; Rodriguez, L; Gasco, MR
   Scale-up of the preparation process of solid lipid nanospheres. Part I
   INTERNATIONAL JOURNAL OF PHARMACEUTICS
   
   E. Marengo et al., "Scale-up of the preparation process of solid lipid nanospheres. Part I", INT J PHARM, 205(1-2), 2000, pp. 3-13
6. Zara, GP; Cavalli, R; Fundaro, A; Bargoni, A; Caputo, O; Gasco, MR
   Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)
   PHARMACOLOGICAL RESEARCH
   
   G.P. Zara et al., "Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)", PHARMAC RES, 40(3), 1999, pp. 281-286
7. Pellizzaro, C; Coradini, D; Morel, S; Ugazio, E; Gasco, MR; Daidone, MG
   Cholesteryl butyrate in solid lipid nanospheres as an alternative approachfor butyric acid delivery
   ANTICANCER RESEARCH
   
   C. Pellizzaro et al., "Cholesteryl butyrate in solid lipid nanospheres as an alternative approachfor butyric acid delivery", ANTICANC R, 19(5B), 1999, pp. 3921-3925